Variant Phenotype Annotation
证据URL
https://www.pharmgkb.org/variantAnnotation/1444935762
总结
CYP2D6 poor metabolizers and intermediate metabolizers are not associated with decreased risk of Recurrence when treated with tamoxifen in women with Breast Neoplasms as compared to CYP2D6 normal metabolizers.